Susie E. Barker

2.2k total citations
19 papers, 1.1k citations indexed

About

Susie E. Barker is a scholar working on Molecular Biology, Genetics and Ophthalmology. According to data from OpenAlex, Susie E. Barker has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Ophthalmology. Recurrent topics in Susie E. Barker's work include Virus-based gene therapy research (10 papers), Retinal Development and Disorders (9 papers) and RNA Interference and Gene Delivery (5 papers). Susie E. Barker is often cited by papers focused on Virus-based gene therapy research (10 papers), Retinal Development and Disorders (9 papers) and RNA Interference and Gene Delivery (5 papers). Susie E. Barker collaborates with scholars based in United Kingdom, United States and Switzerland. Susie E. Barker's co-authors include Robin R. Ali, Yanaí Durán, Alexander J. Smith, Robert E. MacLaren, James Bainbridge, Ulrich F. O. Luhmann, Scott Robbie, Kamaljit S. Balaggan, Christine Kinnon and Adrian J. Thrasher and has published in prestigious journals such as Nature Medicine, Biochemistry and British Journal of Cancer.

In The Last Decade

Susie E. Barker

18 papers receiving 1.1k citations

Peers

Countries citing papers authored by Susie E. Barker

Since Specialization

Citations

This map shows the geographic impact of Susie E. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susie E. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susie E. Barker more than expected).

Fields of papers citing papers by Susie E. Barker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susie E. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susie E. Barker. The network helps show where Susie E. Barker may publish in the future.

Co-authorship network of co-authors of Susie E. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Susie E. Barker. A scholar is included among the top collaborators of Susie E. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susie E. Barker. Susie E. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Enhanced Ccl2-Ccr2 signaling drives more severe choroidal neovascularization with aging 2016 ·Neurobiology of Aging ·Scott Robbie, Anastasios Georgiadis, Susie E. Barker, Yanaí Durán, Alexander J. Smith, Robin R. Ali, Ulrich F. O. Luhmann, James Bainbridge	25
2	Gene Therapy for Noninfectious Uveitis 2012 ·Ocular Immunology and Inflammation ·Colin J. Chu, Susie E. Barker, Andrew D. Dick, Robin R. Ali	12
3	Absence Of Ocular Malignant Transformation After Subretinal Delivery Of Raav2/2 Or Hiv-1 Vectors In P53 Knockout Mice 2011 ·Investigative Ophthalmology & Visual Science ·Kamaljit S. Balaggan, Yanaí Durán, Prateek K. Buch, Angus MacNeil, Scott Robbie, Susie E. Barker, Anastasios Georgiadis, James Bainbridge, Alexander J. Smith, Robin R. Ali	1
4	Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient mice 2011 ·Gene Therapy ·Kamaljit S. Balaggan, Yanaí Durán, Anastasios Georgiadis, Caroline Thaung, Susie E. Barker, Prateek K. Buch, Alex MacNeil, Scott Robbie, James Bainbridge, Alexander J. Smith, Robin R. Ali	11
5	Gene Augmentation Trials Using the Rpe65-Deficient Dog: Contributions Towards Development and Refinement of Human Clinical Trials 2011 ·Advances in experimental medicine and biology ·Simon M. Petersen‐Jones, (unknown), Joshua T. Bartoe, Freya M. Mowat, Susie E. Barker, Alexander J. Smith, James Bainbridge, Robin R. Ali	8
6	Gene therapy in the second eye of RPE65-deficient dogs improves retinal function 2010 ·Gene Therapy ·(unknown), Joshua T. Bartoe, Susie E. Barker, Alexander J. Smith, Paul Curran, James Bainbridge, Robin R. Ali, Simon M. Petersen‐Jones	56
7	Long-Term Survival of Photoreceptors Transplanted into the Adult Murine Neural Retina Requires Immune Modulation 2010 ·Stem Cells ·Emma L. West, R. A. Pearson, Susie E. Barker, Ulrich F. O. Luhmann, Robert E. MacLaren, Amanda C. Barber, Yanaí Durán, Alexander J. Smith, Jane C. Sowden, Robin R. Ali	98
8	Subretinal delivery of adeno‐associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice 2009 ·The Journal of Gene Medicine ·Susie E. Barker, Cathryn Broderick, Scott Robbie, Yanaí Durán, M Natkunarajah, Prateek K. Buch, Kamaljit S. Balaggan, Robert E. MacLaren, James Bainbridge, Alexander J. Smith, Robin R. Ali	43
9	The Drusenlike Phenotype in AgingCcl2-Knockout Mice Is Caused by an Accelerated Accumulation of Swollen Autofluorescent Subretinal Macrophages 2009 ·Investigative Ophthalmology & Visual Science ·Ulrich F. O. Luhmann, Scott Robbie, Peter Munro, Susie E. Barker, Yanaí Durán, Vy Luong, F.W. Fitzke, James Bainbridge, Robin R. Ali, Robert E. MacLaren	180
10	Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis 2008 ·Gene Therapy ·(unknown), Susie E. Barker, Cathryn Broderick, M Natkunarajah, Yanaí Durán, Scott Robbie, James Bainbridge, Alexander J. Smith, (unknown), Andrew D. Dick, Robin R. Ali	45
11	Synthesis of Bifunctional Integrin‐Binding Peptides Containing PEG Spacers of Defined Length for Non‐Viral Gene Delivery 2008 ·European Journal of Organic Chemistry ·(unknown), (unknown), (unknown), Susie E. Barker, P. Ayazi Shamlou, Stephen L. Hart, (unknown), Alethea B. Tabor	14
12	Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12 2007 ·British Journal of Cancer ·Susie E. Barker, (unknown), Elena K. Siapati, (unknown), Christine Kinnon, Adrian J. Thrasher, Stephen L. Hart	30
13	Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8 2007 ·Gene Therapy ·M Natkunarajah, (unknown), Jenny McIntosh, Yanaí Durán, Susie E. Barker, Alexander J. Smith, A C Nathwani, Robin R. Ali	114
14	Biophysical Characterization of an Integrin-Targeted Lipopolyplex Gene Delivery Vector 2007 ·Biochemistry ·M.F. Mohd Mustapa, Paul C. Bell, Christopher A. Hurley, Alastair Nicol, Erwann Guénin, Sarben Sarkar, (unknown), Susie E. Barker, John B. Wong, (unknown), Brigitte Papahadjopoulos‐Sternberg, P. Ayazi Shamlou, (unknown), Stephen L. Hart, Daniel Zicha, Alethea B. Tabor	28
15	Effective gene therapy with nonintegrating lentiviral vectors 2006 ·Nature Medicine ·Rafael J. Yáñez‐Muñoz, Kamaljit S. Balaggan, Angus MacNeil, Steven J. Howe, Manfred Schmidt, Alexander J. Smith, Prateek K. Buch, Robert E. MacLaren, Patrick N. Anderson, Susie E. Barker, Yanaí Durán, Cynthia C. Bartholomae, Christof von Kalle, John R. Heckenlively, Christine Kinnon, Robin R. Ali, Adrian J. Thrasher	360
16	EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV 2006 ·Gene Therapy ·Kamaljit S. Balaggan, K. Binley, (unknown), Robert E. MacLaren, Sharifah Iqball, Yanaí Durán, R. A. Pearson, O. Kan, Susie E. Barker, Andrew J. H. Smith, James Bainbridge, Simon Naylor, Robin R. Ali	47
17	Targeted Gene Delivery to Human Airway Epithelial Cells with Synthetic Vectors Incorporating Novel Targeting Peptides Selected by Phage Display 2004 ·Journal of drug targeting ·(unknown), Barry J. Marshall, (unknown), Susie E. Barker, (unknown), (unknown), Paul C. Bell, Douglas H. Lester, Alethea B. Tabor, (unknown), Nigel Klein, Stephen L. Hart	44
18	Transgenic lupin cultivar immune to bean yellow mosaic virus 2004 ·Murdoch Research Repository (Murdoch University) ·Stephen J. Wylie, (unknown), (unknown), (unknown), Nicola F. Fletcher, Susie E. Barker, Peter G. Smith, M. G. K. Jones	1
19	Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12 2003 ·British Journal of Cancer ·(unknown), Susie E. Barker, Christine Kinnon, Antony Michalski, Ronald Anderson, P M Brickell, Adrian J. Thrasher, Stephen L. Hart	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact